Journal
RESPIRATORY MEDICINE AND RESEARCH
Volume 80, Issue -, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.resmer.2021.100865
Keywords
Non-small cell lung cancer; MicroRNA-4732-5p; Prognosis; Progression
Categories
Ask authors/readers for more resources
miR-4732-5p expression is decreased in NSCLC and is associated with patient prognosis, potentially inhibiting proliferation, migration, and invasion of NSCLC cells by modulating TSPAN13.
Background:: Non-small cell lung cancer (NSCLC) is the leading cause of cancer death with increasing morbidity and mortality. MicroRNA-4732-5p (miR-4732-5p) has been reported to be dysregulated in various cancers and identified as a tumor suppressor. This study aims to explore the expression and role of miR-4732-5p in NSCLC. Methods:: Reverse transcription-quantitative polymerase chain reaction (qRT-PCR) assay was employed to detect the expression of miR-4732-5p in NSCLC. With the help of Kaplan-Meier survival and Cox regression, the prognostic significance of miR-4732-5p was investigated. Meanwhile, the effects of miR-4732-5p on cell proliferation, migration, and invasion were also studied. Results:: The expression of miR-4732-5p decreased in NSCLC tissues and cells. The downregulation of miR-4732-5p was closely associated with lymph node metastasis, TNM stage, and poor prognosis. Multivariate Cox regression analysis results showed that miR-4732-5p was an independent prognosis factor for NSCLC. In addition, the overexpression of miR-4732-5p inhibited the proliferation, migration, and invasion of NSCLC cells through modulating TSPAN13. Conclusions:: These data showed that miR-4732-5p might be involved in the development of NSCLC, which can act as an independent prognostic biomarker and therapeutic target. (C) 2021 SPLF and Elsevier Masson SAS. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available